medRxiv.2021.https://doi.org/10.1101/2021.07.13.21260404;

Paper Title : 

Pre-existing antibodies targeting a dominant linear antibody epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped immune responses elicited by a candidate vaccine

 

MesGen Biotech Product in this paper : 

Cat.No.MG882.Single-Component TMB Substrate